SB
SPARX BIOPHARMACEUTICAL CORP
The startup utilizes machine learning algorithms to analyze complex multi-dimensional public data, including web articles and forum discussions, to extract valuable clinical signals. This approach enables clients to develop multi-specific antibodies for the treatment of solid tumors, addressing the challenge of limited actionable insights in biopharmaceutical research.
- Artificial Intelligence
- Data & Analytics
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$30MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup utilizes machine learning algorithms to analyze complex multi-dimensional public data, including web articles and forum discussions, to extract valuable clinical signals. This approach enables clients to develop multi-specific antibodies for the treatment of solid tumors, addressing the challenge of limited actionable insights in biopharmaceutical research.